113 related articles for article (PubMed ID: 29350745)
1. TiO
Batt J; Milward M; Chapple I; Grant M; Roberts H; Addison O
Eur Cell Mater; 2018 Jan; 35():13-24. PubMed ID: 29350745
[TBL] [Abstract][Full Text] [Related]
2. Titanium dioxide (TiO2) nanoparticles induce neutrophil influx and local production of several pro-inflammatory mediators in vivo.
Gonçalves DM; Girard D
Int Immunopharmacol; 2011 Aug; 11(8):1109-15. PubMed ID: 21426949
[TBL] [Abstract][Full Text] [Related]
3. Neutrophil migration towards C5a and CXCL8 is prevented by non-steroidal anti-inflammatory drugs via inhibition of different pathways.
Bertolotto M; Contini P; Ottonello L; Pende A; Dallegri F; Montecucco F
Br J Pharmacol; 2014 Jul; 171(14):3376-93. PubMed ID: 24597536
[TBL] [Abstract][Full Text] [Related]
4. N-acetylated Proline-Glycine-Proline induced G-protein dependent chemotaxis of neutrophils is independent of CXCL8 release.
Overbeek SA; Henricks PA; Srienc AI; Koelink PJ; de Kruijf P; Lim HD; Smit MJ; Zaman GJ; Garssen J; Nijkamp FP; Kraneveld AD; Folkerts G
Eur J Pharmacol; 2011 Oct; 668(3):428-34. PubMed ID: 21458443
[TBL] [Abstract][Full Text] [Related]
5. The effect of the decoy molecule PA401 on CXCL8 levels in bronchoalveolar lavage fluid of patients with cystic fibrosis.
McElvaney OJ; O'Reilly N; White M; Lacey N; Pohl K; Gerlza T; Bergin DA; Kerr H; McCarthy C; O'Brien ME; Adage T; Kungl AJ; Reeves EP; McElvaney NG
Mol Immunol; 2015 Feb; 63(2):550-8. PubMed ID: 25453468
[TBL] [Abstract][Full Text] [Related]
6. Neutrophil chemotaxis caused by chronic obstructive pulmonary disease alveolar macrophages: the role of CXCL8 and the receptors CXCR1/CXCR2.
Kaur M; Singh D
J Pharmacol Exp Ther; 2013 Oct; 347(1):173-80. PubMed ID: 23912333
[TBL] [Abstract][Full Text] [Related]
7. Genetic variation influences immune responses in sensitive rats following exposure to TiO2 nanoparticles.
Gustafsson A; Jonasson S; Sandström T; Lorentzen JC; Bucht A
Toxicology; 2014 Dec; 326():74-85. PubMed ID: 25456268
[TBL] [Abstract][Full Text] [Related]
8. A novel phenylcyclohex-1-enecarbothioamide derivative inhibits CXCL8-mediated chemotaxis through selective regulation of CXCR2-mediated signalling.
Ha H; Bensman T; Ho H; Beringer PM; Neamati N
Br J Pharmacol; 2014 Mar; 171(6):1551-65. PubMed ID: 24354854
[TBL] [Abstract][Full Text] [Related]
9. Neurotoxicity mediated by oxidative stress caused by titanium dioxide nanoparticles in human neuroblastoma (SH-SY5Y) cells.
Ferraro SA; Domingo MG; Etcheverrito A; Olmedo DG; Tasat DR
J Trace Elem Med Biol; 2020 Jan; 57():126413. PubMed ID: 31606305
[TBL] [Abstract][Full Text] [Related]
10. Titanium dioxide nanoparticle stimulating pro-inflammatory responses in vitro and in vivo for inhibited cancer metastasis.
Zhao F; Wang C; Yang Q; Han S; Hu Q; Fu Z
Life Sci; 2018 Jun; 202():44-51. PubMed ID: 29625194
[TBL] [Abstract][Full Text] [Related]
11. Short Preirradiation of TiO
Kose O; Tomatis M; Turci F; Belblidia NB; Hochepied JF; Pourchez J; Forest V
Chem Res Toxicol; 2021 Mar; 34(3):733-742. PubMed ID: 33459025
[TBL] [Abstract][Full Text] [Related]
12. Human CD4+ FOXP3+ regulatory T cells produce CXCL8 and recruit neutrophils.
Himmel ME; Crome SQ; Ivison S; Piccirillo C; Steiner TS; Levings MK
Eur J Immunol; 2011 Feb; 41(2):306-12. PubMed ID: 21268001
[TBL] [Abstract][Full Text] [Related]
13. Parallel phosphatidylinositol 3-kinase (PI3K)-dependent and Src-dependent pathways lead to CXCL8-mediated Rac2 activation and chemotaxis.
Sai J; Raman D; Liu Y; Wikswo J; Richmond A
J Biol Chem; 2008 Sep; 283(39):26538-47. PubMed ID: 18662984
[TBL] [Abstract][Full Text] [Related]
14. Biological activity of CXCL8 forms generated by alternative cleavage of the signal peptide or by aminopeptidase-mediated truncation.
Mortier A; Berghmans N; Ronsse I; Grauwen K; Stegen S; Van Damme J; Proost P
PLoS One; 2011; 6(8):e23913. PubMed ID: 21904597
[TBL] [Abstract][Full Text] [Related]
15. Titanium dioxide nanoparticles induce endothelial cell apoptosis via cell membrane oxidative damage and p38, PI3K/Akt, NF-κB signaling pathways modulation.
Gholinejad Z; Khadem Ansari MH; Rasmi Y
J Trace Elem Med Biol; 2019 Jul; 54():27-35. PubMed ID: 31109618
[TBL] [Abstract][Full Text] [Related]
16. Truncation of CXCL8 to CXCL8(9-77) enhances actin polymerization and in vivo migration of neutrophils.
Metzemaekers M; Vandendriessche S; Berghmans N; Gouwy M; Proost P
J Leukoc Biol; 2020 Jun; 107(6):1167-1173. PubMed ID: 32272490
[TBL] [Abstract][Full Text] [Related]
17. Titanium dioxide nanoparticles prime a specific activation state of macrophages.
Huang C; Sun M; Yang Y; Wang F; Ma X; Li J; Wang Y; Ding Q; Ying H; Song H; Wu Y; Jiang Y; Jia X; Ba Q; Wang H
Nanotoxicology; 2017 Aug; 11(6):737-750. PubMed ID: 28669258
[TBL] [Abstract][Full Text] [Related]
18. The impact of photocatalytic Ag/TiO
Rebleanu D; Gaidau C; Voicu G; Constantinescu CA; Mansilla Sánchez C; Rojas TC; Carvalho S; Calin M
Toxicology; 2019 Mar; 416():30-43. PubMed ID: 30711708
[TBL] [Abstract][Full Text] [Related]
19. A CXCL8 receptor antagonist based on the structure of N-acetyl-proline-glycine-proline.
Jackson PL; Noerager BD; Jablonsky MJ; Hardison MT; Cox BD; Patterson JC; Dhanapal B; Blalock JE; Muccio DD
Eur J Pharmacol; 2011 Oct; 668(3):435-42. PubMed ID: 21458447
[TBL] [Abstract][Full Text] [Related]
20. A C-terminal CXCL8 peptide based on chemokine-glycosaminoglycan interactions reduces neutrophil adhesion and migration during inflammation.
Martínez-Burgo B; Cobb SL; Pohl E; Kashanin D; Paul T; Kirby JA; Sheerin NS; Ali S
Immunology; 2019 Jun; 157(2):173-184. PubMed ID: 31013364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
